Genmab — September 2025
-
ASCO25: Merus wins in head-to-head with Bicara for head and neck cancer https://finance.yahoo.com/news/asco-2025-merus-wins-head-105450309.html
-
Så slutter vores positive up trend. Det er slut med at prale af ingen gæld tvært imod blive Gmab nu et meget gælds tynget selskab men en financial leverage på > 5
Det skal nok blive godt på den lamge bane men øv for trenden hvis jeg ikke tager meget fejl. -
14/10 09:24
af E L
The new building next to the (also rather new...) Genmab R&D Center in Utrecht was opened. it will house Genmab, Merus and ImmunoPrecise Antibodies https://vastgoedberichten.nl/2023/10/13/kadans-opent-innovatiecentrum-accelerator-utrecht-op-utrecht-science-park/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind